Dramatic Prostate Specific Antigen Decrease in Response to Discontinuation of Megestrol Acetate in Advanced Prostate Cancer
- 1 June 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- p. 1946-1947
- https://doi.org/10.1097/00005392-199506000-00066
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Prostate-specific antigen decline after casodex withdrawal: Evidence for an antiandrogen withdrawal syndromeUrology, 1994
- Surprising Activity of Flutamide Withdrawal, When Combined With Aminoglutethimide, in Treatment of "Hormone-Refractory" Prostate CancerJNCI Journal of the National Cancer Institute, 1994
- Response to Flutamide Withdrawal in Advanced Prostate Cancer in Progression Under Combination TherapyJournal of Urology, 1993
- Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.Journal of Clinical Oncology, 1993
- Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activationBiochemistry, 1992
- Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretionThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- The Proliferative Effect of “Anti-Androgens” on the Androgen-Sensitive Human Prostate Tumor Cell Line LNCaPEndocrinology, 1990
- Aberrant response in vitro of hormone‐responsive prostate cancer cells to antiandrogensThe Prostate, 1989